Shares of Elevance Health Inc. ELV slipped 1.63% to $427.19 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.08% to ...

The Davenport Value & Income Fund (DVIPX) generated a -4.18% total return in the fourth quarter of 2024. Click here to read ...

Wells Fargo analyst Stephen Baxter reiterated a Buy rating on Elevance Health (ELV – Research Report) yesterday and set a price target of ...

In an economic environment marked by volatility and uncertainty, selecting a dependable insurance partner is essential for ...

StockNews.com upgraded Elevance Health from a "hold" to a "buy," signaling increased investor confidence in the company. Analysts have had mixed opinions, with Cantor Fitzgerald maintaining an ...

Elevance Health (NYSE:ELV – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Thursday. Several other ...

Elevance Health settled a class-action lawsuit over denial of coverage for minimally invasive sacroiliac joint fusion surgery ...

Elevance Health‘s stock rating was upgraded from “hold” to “buy” by Argus, with a price target of $450. Several other firms ...

Elevance Health Inc. has agreed to pay $3.3 million to settle a lawsuit accusing it of wrongfully denying coverage for a ...

Nayak’s pivotal, innovative work in AI and engineering is helping push the healthcare industry into the future.

Elevance Health Inc. signed a class settlement valued at more than $2.5 million in a lawsuit saying it wrongly denied ...

U.S. health benefits company Elevance Health, Inc. ELV appears undervalued. It is currently trading at 12.25X forward 12-month earnings, below its five-year median of 13.44X and the industry average ...